PNPLA3 and metabolic dysfunction-associated steatotic liver disease: PNPLA3 has been associated (with the strongest correlation among other identified genes) to increased risk of steatosis, fibrosis and HCC in both NAFLD and ArLD [70,72,74,100,101].